Yazar "Emiralioğlu, Nagehan" için listeleme
-
Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators
Büyükşahin, Halime Nayır; Emiralioğlu, Nagehan; Yalçın, Ebru; Şen, Velat; Şen, Hadice Selimoğlu; Arslan, Hüseyin; Başkan, Azer Kılıç; Can, Demet (John Wiley and Sons, 2024)Introduction: Cystic fibrosis transmembrane conductance regulator (CFTR) modulator drugs target the underlying defect and improve CFTR function. They are a part of standard care in many countries, but not all patients are ... -
Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study
Emiralioğlu, Nagehan; Çakır, Banu; Sertçelik, Ahmet; Yalçın, Ebru; Kiper, Nural; Şen, Velat; Altıntaş, Derya Ufuk; Can, Demet (John Wiley and Sons, 2024)Background: The decline in pulmonary function is a predictor of disease progression in patients with cystic fibrosis (CF). This study aimed to determine the decline rate of percent predicted forced expiratory volume in 1 ... -
The success of the cystic fibrosis registry of Turkey for improvement of patient care
Asfuroğlu, Pelin; Eyüboğlu, Tuğba Sişmanlar; Aslan, Ayşe Tana; Gürsoy, Tuğba Ramasli; Emiralioğlu, Nagehan; Yalçın, Ebru; Kiper, Nural; Can, Demet (Wiley, 2022)Background Cystic fibrosis (CF) registries play an essential role in improving disease outcomes of people with CF. This study aimed to evaluate the association of newly established CF registry system in Turkey on follow-up, ...
